1. Home
  2. CANG vs IMUX Comparison

CANG vs IMUX Comparison

Compare CANG & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cango Inc.  each representing two (2)

CANG

Cango Inc. each representing two (2)

HOLD

Current Price

$0.41

Market Cap

185.4M

Sector

Technology

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$9.98

Market Cap

152.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CANG
IMUX
Founded
2010
2016
Country
United States
United States
Employees
N/A
66
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.4M
152.6M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
CANG
IMUX
Price
$0.41
$9.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$3.00
$45.00
AVG Volume (30 Days)
1.4M
2.5M
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$428.72
N/A
Revenue Next Year
$18.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.51
52 Week High
$5.75
$10.91

Technical Indicators

Market Signals
Indicator
CANG
IMUX
Relative Strength Index (RSI) 40.60 89.55
Support Level $0.33 $0.74
Resistance Level $0.50 N/A
Average True Range (ATR) 0.06 0.36
MACD 0.01 1.08
Stochastic Oscillator 11.24 91.80

Price Performance

Historical Comparison
CANG
IMUX

About CANG Cango Inc. each representing two (2)

Cango Inc is a Bitcoin mining company with a vision to establish an integrated, world-wide infrastructure platform capable of powering the future digital economy. The Company's mining operations span over 40 sites across North America, the Middle East, South America, and East Africa. Since entering the digital asset space in November 2024, Cango has activated pilot projects in both integrated energy solutions and distributed AI computing. In parallel, Cango continues to operate an online international used car export business through its subsidiary.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Share on Social Networks: